Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 182

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapy

Bhaskaran, Krishnan, Mussini, Cristina, Antinori, Andrea, Walker, Ann Sarah, Dorrucci, Maria, Sabin, Caroline, Phillips, Andrew, Porter, Kholoud, CASCADE Collaboration · 2008 · Annals of Neurology

Abstract

Objective: Though effective anti–human immunodeficiency virus (HIV) therapies are now available, they have variable penetration into the brain. We therefore aimed to assess changes over calendar time in the risk for HIV‐associated dementia (HIV‐D), and factors associated with HIV‐D risk. Methods: Using Concerted Action on Seroconversion to AIDS and Death in Europe (CASCADE) data, we analyzed factors associated with time from HIV seroconversion to HIV‐D using Cox models with time‐updated covariates. The effect of duration of infection was explored using flexible parametric survival models. Results: 222 of 15,380 seroconverters developed HIV‐D. The incidence per 1,000 person‐years was 6.49 pre‐1997 (before highly active antiretroviral therapy was available), declining to 0.66 by 2003 to 2006. Compared with most recent CD4 count ≥ 350 cells/mm 3, the adjusted relative risk (95% confidence interval) of HIV‐D was 3.47 (1.91–6.28), 10.19 (5.72–18.15), and 39.03 (22.96–66.36) at 200 to 349, 100 to 199, and 0 to 99 cells/mm 3, respectively. In 2003 to 2006, older age at seroconversion (relative risk = 3.24 per 10‐year increase [95% confidence interval, 2.00–5.24]) and previous acquired immune deficiency syndrome diagnosis (relative risk = 4.92 [95% confidence interval, 1.43–16.92]) were associated with HIV‐D risk, independently of current CD4 count. HIV‐D risk appeared to increase during chronic infection, by 48% at 10 years after seroconversion compared with the lowest risk at 1.8 years. Interpretation: HIV‐D incidence has reduced markedly since 1997. However, patients with low (<200 cells/mm 3) or even intermediate (200–349 cells/mm 3) CD4 counts, previous acquired immune deficiency syndrome diagnosis, longer HIV infection duration, and older age at seroconversion are at increased risk and should be closely monitored for neurocognitive disorders. Ann Neurol 2007

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21225

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 182

Metadata

Authors
Bhaskaran, K., Mussini, C., Antinori, A., Walker, A. S., Dorrucci, M., Sabin, C., Phillips, A., Porter, K., & CASCADE Collaboration
Venue
Annals of Neurology
Publisher
Wiley
Published
2008-02
Volume
63
Issue
2
Pages
213-221
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2123185078
Cited by
182
References
1
FWCI
2.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapy. https://app.cochat.ai/papers/10.1002/ana.21225
The paper
Bhaskaran, K., Mussini, C., Antinori, A., Walker, A. S., Dorrucci, M., Sabin, C., Phillips, A., Porter, K., & CASCADE Collaboration. (2008). Changes in the incidence and predictors of human immunodeficiency virus–associated dementia in the era of highly active antiretroviral therapy. Annals of Neurology. https://doi.org/10.1002/ana.21225

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.